Publication date
August 2018
DOIAbstract
Comparison of uptake in unaffected bone tissue of PSMA PET tracers [18F]-DCFPyL and [68Ga]-HBED-CC
Comparison of uptake in unaffected bone tissue of PSMA PET tracers [18F]-DCFPyL and [68Ga]-HBED-CC
PURPOSE: Detailed data comparing the biodistribution of PSMA radioligands is still scarce, raising c...
PET is increasingly used for prostate cancer (PCa) diagnostics. Important PCa radiotracers include 6...
Prostate-specific membrane antigen (PSMA), expressed by most prostate carcinomas (PCa), is a promisi...
INTRODUCTION:[68Ga]PSMA-HBED-CC and [18F]DCFPyL show a high potential for the detection of recurrent...
1) Radiochemical Purity2) Bone Uptake in metastases-negative patients3) lesional uptake in metastasi...
[68Ga]PSMA-HBED-CC and[18F]DCFPyL show a high potential for the detection of recurrent prostate canc...
a) Average SUVs in unaffected bone tissue in 17 patients without bone metastases. b) SUVmean and SUV...
Objective: The aim of this study was to compare images from Tc-99m MDP bone scan (BS) and Ga-68 PSMA...
Exemplary PET dataset (a) and placement of VOIs (b,c). Red-dotted area was excluded from the analysi...
A patient with bone metastases of prostate cancer was referred for 68Ga-PSMA-11 PET/CT. Compared to ...
A wide variety of 18F-labeled PSMA-targeting PET radiotracers have been developed, including [18F]Al...
18F-prostate-specific membrane antigen (PSMA)-1007 is excreted mainly through the liver. We benchmar...
Purpose: Bone scintigraphy is the standard of reference in bone metastases in prostate cancer patien...
PET is increasingly used for prostate cancer (PCa) diagnostics. Important PCa radiotracers include 6...
Purpose: Improved logistics and availability led to a rapid increase in the use of [18F]-PSMA-1007 f...
PURPOSE: Detailed data comparing the biodistribution of PSMA radioligands is still scarce, raising c...
PET is increasingly used for prostate cancer (PCa) diagnostics. Important PCa radiotracers include 6...
Prostate-specific membrane antigen (PSMA), expressed by most prostate carcinomas (PCa), is a promisi...
INTRODUCTION:[68Ga]PSMA-HBED-CC and [18F]DCFPyL show a high potential for the detection of recurrent...
1) Radiochemical Purity2) Bone Uptake in metastases-negative patients3) lesional uptake in metastasi...
[68Ga]PSMA-HBED-CC and[18F]DCFPyL show a high potential for the detection of recurrent prostate canc...
a) Average SUVs in unaffected bone tissue in 17 patients without bone metastases. b) SUVmean and SUV...
Objective: The aim of this study was to compare images from Tc-99m MDP bone scan (BS) and Ga-68 PSMA...
Exemplary PET dataset (a) and placement of VOIs (b,c). Red-dotted area was excluded from the analysi...
A patient with bone metastases of prostate cancer was referred for 68Ga-PSMA-11 PET/CT. Compared to ...
A wide variety of 18F-labeled PSMA-targeting PET radiotracers have been developed, including [18F]Al...
18F-prostate-specific membrane antigen (PSMA)-1007 is excreted mainly through the liver. We benchmar...
Purpose: Bone scintigraphy is the standard of reference in bone metastases in prostate cancer patien...
PET is increasingly used for prostate cancer (PCa) diagnostics. Important PCa radiotracers include 6...
Purpose: Improved logistics and availability led to a rapid increase in the use of [18F]-PSMA-1007 f...
PURPOSE: Detailed data comparing the biodistribution of PSMA radioligands is still scarce, raising c...
PET is increasingly used for prostate cancer (PCa) diagnostics. Important PCa radiotracers include 6...
Prostate-specific membrane antigen (PSMA), expressed by most prostate carcinomas (PCa), is a promisi...
Add to ORKG